RKL Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,234
Closed -$819K 126
2019
Q3
$819K Sell
8,234
-412
-5% -$39.1K 0.16% 81
2019
Q2
$798K Sell
8,646
-137
-2% -$13K 0.15% 83
2019
Q1
$829K Sell
8,783
-114
-1% -$9.97K 0.16% 81
2018
Q4
$570K Sell
8,897
-1,416
-14% -$105K 0.13% 88
2018
Q3
$921K Sell
10,313
-499
-5% -$44.1K 0.2% 78
2018
Q2
$860K Sell
10,812
-2,965
-22% -$246K 0.19% 80
2018
Q1
$1.22M Sell
13,777
-7,824
-36% -$751K 0.29% 68
2017
Q4
$2.26M Sell
21,601
-6,433
-23% -$726K 0.56% 44
2017
Q3
$4.08M Sell
28,034
-7,141
-20% -$973K 1.15% 28
2017
Q2
$4.57M Sell
35,175
-7,073
-17% -$867K 1.45% 27
2017
Q1
$5.26M Sell
42,248
-7,081
-14% -$847K 2.11% 20
2016
Q4
$5.71M Sell
49,329
-3,741
-7% -$417K 2.75% 14
2016
Q3
$5.55M Sell
53,070
-388
-0.7% -$42K 2.8% 19
2016
Q2
$5.38M Buy
53,458
+400
+0.8% +$41.4K 2.8% 19
2016
Q1
$5.31M Buy
53,058
+29,070
+121% +$2.99M 3.05% 18
2015
Q4
$6.49K Sell
23,988
-30,797
-56% -$3.56M 3.01% 10
2015
Q3
$5.93M Sell
54,785
-930
-2% -$115K 3.74% 9
2015
Q2
$6.45M Buy
55,715
+198
+0.4% +$22.6K 3.87% 8
2015
Q1
$6.4M Buy
55,517
+4,640
+9% +$554K 3.87% 8
2014
Q4
$5.69M Buy
50,877
+758
+2% +$79.9K 3.71% 9
2014
Q3
$4.75M Buy
50,119
+5,853
+13% +$528K 3.32% 12
2014
Q2
$3.8M Buy
44,266
+5,786
+15% +$440K 2.78% 16
2014
Q1
$2.69M Buy
+38,480
New +$3.05M 2.03% 23

Other funds holding CELG

RKL Wealth Management's CELG Position: Q4 2019 in Review

RKL Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,234 shares — an estimated $819K sold.

RKL Wealth Management first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $6.45M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • RKL Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • RKL Wealth Management sold 8,234 Celgene Corp shares in Q4 2019, an estimated $819K.
  • RKL Wealth Management first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • RKL Wealth Management's Celgene Corp position peaked at $6.45M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on RKL Wealth Management's 13F filing for Q4 2019, filed 4 Feb 2020.